Pomerantz Law Firm Investigates Claims on Behalf of Investors of Ceradyne, Inc.
October 02 2012 - 11:29AM
Business Wire
Pomerantz Grossman Hufford Dahlstrom & Gross LLP is
investigating claims on behalf of investors of Ceradyne, Inc.
(“Ceradyne” or the “Company”) (NASDAQ: CRDN) (ISIN: US1567101050)
concerning the proposed acquisition of Ceradyne by 3M in a cash
transaction valued at approximately $860 million.
The investigation concerns whether the Ceradyne directors are
breaching their fiduciary duties by failing to adequately shop the
Company and maximize shareholder value. Under the terms of the
agreement, Ceradyne shareholders would receive $35.00 in cash per
share of Ceradyne common stock. However, Ceradyne stock traded
above the offered price in the past year.
Ceradyne shareholders seeking more information about this
acquisition are advised to contact Samuel J. Adams at
sjadams@pomlaw.com or 212-661-1100 or 888-476-6529, ext. 300.
The Pomerantz Firm, with offices in New York, Chicago and San
Diego, is acknowledged as one of the premier firms in the areas of
corporate, securities, and antitrust class litigation. Founded by
the late Abraham L. Pomerantz, known as the dean of the class
action bar, the Pomerantz Firm pioneered the field of securities
class actions. Today, more than 75 years later, the Pomerantz Firm
continues in the tradition he established, fighting for the rights
of the victims of securities fraud, breaches of fiduciary duty, and
corporate misconduct. The Firm has recovered numerous
multimillion-dollar damages awards on behalf of defrauded
investors. See www.pomerantzlaw.com.
Ceradyne, Inc. (MM) (NASDAQ:CRDN)
Historical Stock Chart
From Jul 2024 to Jul 2024
Ceradyne, Inc. (MM) (NASDAQ:CRDN)
Historical Stock Chart
From Jul 2023 to Jul 2024